marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q1
added 05-15-2023
9 Meters Biopharma Financial Ratios 2011-2024 | NMTR
Annual Financial Ratios 9 Meters Biopharma
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.4 | -0.3 | -2.4 | -0.9 | -2.4 | -0.7 | -1.5 | - | - | - | - | - |
P/S |
- | - | - | - | - | 3.1 | 2.3 | - | - | - | - | - |
EPS |
-3.4 | -3.0 | -0.6 | -0.8 | -1.0 | -9.4 | 1.1 | 2.6 | - | - | - | - |
EV (Enterprise Value) |
35.6 M | -26.5 M | 116 M | 36 M | 61.6 M | 8.04 M | 11.7 M | 10.8 M | 11.4 M | 2.47 M | - | - |
EBITDA per Share |
-3.24 | -3.02 | -0.562 | -0.728 | -0.735 | -6.94 | -10.5 | - | - | - | - | - |
EV/EBITDA |
1.0 | -1.8 | -1.0 | -3.1 | -1.0 | -1.3 | - | - | - | - | - | |
PEG |
-0.01 | -0.01 | -0.08 | -0.05 | -0.03 | -0.04 | -0.05 | - | - | - | - | - |
P/B |
7.3 | 0.3 | 4.6 | -2.7 | -15.6 | -2.9 | 3.7 | - | - | - | - | - |
P/CF |
-0.5 | -0.4 | -7.6 | -1.4 | -3.8 | -1.4 | -1.1 | - | - | - | - | - |
ROE % |
-1823.19 | -88.40 | -191.33 | 281.35 | 660.34 | 401.67 | -249.72 | - | - | - | - | - |
ROA % |
-132.03 | -73.30 | -157.05 | -510.66 | -374.37 | -1170.61 | -96.12 | - | - | - | - | - |
ROCE % |
-1750.31 | -88.36 | -188.42 | 252.58 | 498.05 | 337.86 | -238.87 | - | - | - | - | - |
Current Ratio |
1.1 | 5.9 | 5.7 | 0.4 | 0.6 | 0.3 | 1.0 | - | - | - | - | - |
DSO |
- | - | - | - | - | 17.4 | 76.9 | - | - | - | - | - |
DIO |
- | - | - | - | - | 18.9 | 121.2 | - | - | - | - | - |
DPO |
- | - | - | - | - | 82.7 | 29.4 | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | 36.4 | 198.0 | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | -46.3 | 168.6 | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios 9 Meters Biopharma
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.02 | - | -0.72 | -0.04 | -0.88 | - | -1.06 | -0.03 | -0.03 | - | -0.06 | -0.57 | -0.09 | - | -0.26 | -0.13 | -0.16 | - | -0.03 | -0.16 | -0.7 | - | -0.08 | -0.23 | -0.34 | - | -0.27 | -0.33 | 0.5 | - | 0.45 | 0.38 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.94 | - | -0.67 | -0.04 | -0.88 | - | -1.06 | -0.03 | -0.03 | - | -0.04 | -0.57 | -0.12 | - | -0.18 | -0.18 | 0.16 | - | -0.01 | 0.13 | 0.53 | - | 0.07 | 0.23 | 0.33 | - | -0.33 | -0.22 | -0.43 | - | -417 | -344 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
30.78 | -156.58 | -184.06 | -142.05 | -105.61 | -57.38 | -83.31 | -81.75 | -206.55 | -175.89 | -79.97 | 41.87 | 227.30 | 188.73 | 209.93 | 135.22 | 203.75 | 545.25 | 640.58 | 714.71 | 694.82 | 285.98 | 212.27 | 43.23 | -101.94 | -199.16 | -173.37 | -73.88 | -3.74 | 46.08 | 46.08 | 20.30 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-228.64 | -86.44 | -110.33 | -112.01 | -89.19 | -49.90 | -71.18 | -68.58 | -169.96 | -144.37 | -318.46 | -471.27 | -442.12 | -342.55 | -354.57 | -192.50 | -173.08 | -309.12 | -1762.59 | -3204.04 | -4592.20 | -4360.42 | -4388.79 | -2963.69 | -1529.40 | -76.66 | -107.77 | -110.51 | -115.83 | -55.62 | -55.62 | -24.50 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
22.81 | -152.17 | -179.65 | -142.38 | -105.65 | -57.29 | -76.91 | -69.04 | -194.58 | -174.54 | -106.85 | -19.55 | 183.64 | 86.52 | 92.52 | 30.84 | -125.12 | -395.87 | -415.09 | -440.32 | -370.16 | -73.50 | -168.51 | -244.30 | -258.41 | -196.70 | -172.26 | -52.79 | 1.98 | 43.01 | 43.01 | 18.56 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.6 | 1.1 | 1.5 | 3.3 | 4.7 | 5.8 | 7.7 | 9.6 | 6.5 | 5.6 | 5.6 | 5.6 | 5.6 | 0.4 | 0.4 | 0.6 | 0.5 | 0.6 | - | - | 0.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency